The ORVAC trial: A phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: A statistical analysis plan

Mark A. Jones, Todd Graves, Bianca Middleton, James Totterdell, Thomas L. Snelling, Julie A. Marsh

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)
64 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The ORVAC trial: A phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: A statistical analysis plan'. Together they form a unique fingerprint.

Medicine and Dentistry